Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discordant Reporting of a Previously Undescribed Pathogenic Germline BRCA2 Variant in Blood and Tumor Tissue in a Patient With Pancreatic Adenocarcinoma.

JCO precision oncology - 1 Nov 2021

Kordes Maximilian, Tamborero David, Lagerstedt-Robinson Kristina, Yachnin Jeffrey, Rosenquist Richard, Löhr J-Matthias, Gustafsson Liljefors Maria

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to BRCA2 Protein
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ Cells

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 34994625
DOI: 10.1200/PO.21.00024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discordant Reporting of a Previously Undescribed Pathogenic Germline BRCA2 Variant in Blood and Tumor Tissue in a Patient With Pancreatic Adenocarcinoma.PMID 34994625Read ↗

Emerging cancer risks in BRCA2 pathogenic germline variant carriers.Semantic proximity Read ↗

Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature reviewSemantic proximity Read ↗

Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.Semantic proximity Read ↗

Germline BAP1 mutations misreported as somatic based on tumor-only testing.Semantic proximity Read ↗

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.Semantic proximity Read ↗

Novel BRCA2 c.8434_8435insTT (p. Gly2812Valfs*10) mutation in a family with multiple hematologic malignancies and solid tumors.Semantic proximity Read ↗

Coinheritance of pathogenic variants in ATM and BRCA2 in families with multiple cancers: a case seriesSemantic proximity Read ↗

BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.Semantic proximity Read ↗

BRCA2 germline mutation carrier with five malignancies: a case studySemantic proximity Read ↗

The BRCA1 c.788G > T (NM_007294.4) variant in a high grade serous ovarian cancer (HGSOC) patient: foods for thought.Semantic proximity Read ↗

Familial Genetic Cancer Risk Assessment with respect to a Silent<i>BRCA2</i>mutationSemantic proximity Read ↗

Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.